Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2728 results

Sort By:

Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms

Study ID: NCT07136415
Start Date: 2025-12-01
End Date: 2030-01-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

1000

Intervention / Treatment

Cognitive behavioral therapy for insomnia (CBT-i)

Trazodone

Daridorexant

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Tele-Exercise to Promote Empowered Movement in Individuals With Spinal Cord Injury

Study ID: NCT07022808
Start Date: 2025-12-01
End Date: 2029-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Synchronous Group exercise

Asynchronous exercise (Control)

Sponsor

Drexel University

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Study ID: NCT07195916
Start Date: 2025-12-31
End Date: 2028-08-18
Study Type

Interventional

Study Phase

Phase1

No. of Participants

280

Intervention / Treatment

Ynessa036873

Sponsor

Incyte Corporation

Source: clinicaltrials.gov

Share:
Add to list

Intrathecal Amniotic Fluid Stem Cells for Progressive Multiple Sclerosis

Study ID: NCT06841068
Start Date: 2026-02-01
End Date: 2026-11-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Amniotic fluid or placental CD117 stem cells

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

Sibwatch: Optimizing Intervention Options for Infants and Toddler Siblings of Autistic Children

Study ID: NCT07069413
Start Date: 2026-04-01
End Date: 2032-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

140

Intervention / Treatment

tele-ImPACT

Sponsor

University of Texas at Austin

Source: clinicaltrials.gov

Share:
Add to list

Alveolar Dead Space as Predictor of Organ Failure in Severe Sepsis

Study ID: NCT01315782
Start Date: 2026-12
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment
Sponsor

The University of Texas Health Science Center, Houston

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

Study ID: NCT07221838
Start Date: 2025-12-31
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

75

Intervention / Treatment

Oral Corticosteroid Tapering Schedule

Ravalizumab

Prednisone/Prednisolone

Sponsor

Alexion Pharmaceuticals, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma

Study ID: NCT07154082
Start Date: 2025-12-30
End Date: 2028-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

27

Intervention / Treatment

TACE (transarterial chemoembolization) combined with targeted/immunotherapy

Sponsor

Wei Zhang

Source: clinicaltrials.gov

Share:
Add to list

Investigation of the Genetic and Environmental Causes of Autism: a Multi-Center Study

Study ID: NCT06662591
Start Date: 2025-12-27
End Date: 2028-05-27
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

3000

Intervention / Treatment
Sponsor

Research and Treatment Society of Genetic Disorders

Source: clinicaltrials.gov

Share:
Add to list

Meta Self-efficacy Internet Intervention to Improve Work Self-efficacy and Occupational Well-being in Young Employees

Study ID: NCT06944990
Start Date: 2026-03-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment

Meta self-efficacy internet intervention

Placebo

Sponsor

University of Social Sciences and Humanities, Warsaw

Source: clinicaltrials.gov

Share:
Add to list